AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Alligator Bioscience

Major Shareholding Notification Jul 6, 2023

3138_iss_2023-07-06_36ff84c3-686b-4d75-b5e9-a259b0ee8bd6.pdf

Major Shareholding Notification

Open in Viewer

Opens in native device viewer

Issuer Alligator Bioscience AB

Holder

Avanza Bank Holding AB för Försäkringsaktiebolaget Avanza Pension

Instrument
Instrument Aktier
Before the transaction
Shares Data not given*
Voting rights Data not given*
Transaction
Reason for major shareholding notification Sell
Date 05/07/2023
Limit for number of shares 5 %
Limit for number of votes 5 %
After the transaction
Quantity
Shares 30,985,134
Directly held voting rights 0
Indirectly held voting rights 30,985,134
Percentage
Directly held shares 4.96139 %
Directly held voting rights 0 %
Indirectly held voting rights 4.96819 %

Resulting distribution of total holdings

Percentage of voting
rights:
Number of underlying
shares:
Shares 4.96819 % 30,985,134
Instruments - FITA Ch. 4, section 2, first
paragraph, line 2
Instruments - FITA Ch. 4, section 2,
first paragraph, line 3
- Physically settled
- Cash settled
0.02317 % 144,485
Total 4.99136 % 31,129,619

Group total holdings

Voting rights 31,129,619 Percentage of voting rights 4.99136

Notes (other relevant informations according to law)

Aktierna, samt övriga instrument enligt LHF 4 kap, 2§ första stycket 1 och finansiella instrument enligt LHF 4 kap. 2§ första stycket 3 innehas av Försäkringsaktiebolaget Avanza Pension som är ett helägt dotterbolag till Avanza Bank Holding AB (publ). Det är försäkringskunder som via depåfullmakt har avyttrat de aktuella aktierna.

Published

06/07/2023 10:07

Contact

Name Marie Andersson

Email [email protected]

*Source of information has chosen not to submit the data

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25

Talk to a Data Expert

Have a question? We'll get back to you promptly.